Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Zivkovic

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Physiology & Behavior|January 1, 1987
The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structureD J Sanger, G Perrault, E Morel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Animal models of anxiety and the development of novel anxiolytic drugsD J Sanger, G Perrault, E Morel, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profileK G Lloyd, B Zivkovic, D Sanger, et al.
Pacing and Clinical Electrophysiology : PACE|October 7, 2008
Permanent endovenous pediatric pacing: absence of lead failure--20 years follow-up studyPetar L Stojanov, Dragutin V Savic, Mirjana B Zivkovic, et al.
Psychopharmacology Bulletin|January 1, 1985
The GABA hypothesis of depression and antidepressant drug actionG Bartholini, K G Lloyd, B Scatton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
The gabaergic hypothesis of depressionK G Lloyd, B Zivkovic, B Scatton, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
The psychopharmacology of GABA synapses: update 1989K G Lloyd, P Pichat, B Scatton, et al.
Pharmacopsychiatry|May 1, 1990
Pharmacological and behavioral profile of alpidem as an anxiolyticB Zivkovic, E Morel, D Joly, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtypeJ Benavides, B Peny, A Dubois, et al.
Neuroscience and Biobehavioral Reviews|January 1, 1994
Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypesD J Sanger, J Benavides, G Perrault, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Physiology & Behavior|January 1, 1987
The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structureD J Sanger, G Perrault, E Morel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1991
Animal models of anxiety and the development of novel anxiolytic drugsD J Sanger, G Perrault, E Morel, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profileK G Lloyd, B Zivkovic, D Sanger, et al.
Pacing and Clinical Electrophysiology : PACE|October 7, 2008
Permanent endovenous pediatric pacing: absence of lead failure--20 years follow-up studyPetar L Stojanov, Dragutin V Savic, Mirjana B Zivkovic, et al.
Psychopharmacology Bulletin|January 1, 1985
The GABA hypothesis of depression and antidepressant drug actionG Bartholini, K G Lloyd, B Scatton, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1989
The gabaergic hypothesis of depressionK G Lloyd, B Zivkovic, B Scatton, et al.
Journal of Neural Transmission. Supplementum|January 1, 1990
The psychopharmacology of GABA synapses: update 1989K G Lloyd, P Pichat, B Scatton, et al.
Pharmacopsychiatry|May 1, 1990
Pharmacological and behavioral profile of alpidem as an anxiolyticB Zivkovic, E Morel, D Joly, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtypeJ Benavides, B Peny, A Dubois, et al.
Neuroscience and Biobehavioral Reviews|January 1, 1994
Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypesD J Sanger, J Benavides, G Perrault, et al.
Pageof 8